Creww, a company specializing in open innovation programs, announced on the 6th the establishment of a new company, Creww Capital, which will focus on CVC support and fund management. The new ...

Regional Fish, a pioneer in genome-edited aquaculture, announced on December 26 that it has raised a total of ¥4.07 billion (approximately $25.3 Million) in its Series C funding round. The funding ...

TRUST SMITH, a company dedicated to creating businesses leveraging AI and robotics technologies, announced the launch of TRUST SMITH & CAPITAL on January 1. The firm plans to establish a ...

FUNDiT, a company specializing in M&A and rollups of small to mid-sized IT businesses, announced on December 30 that it has secured a ¥960 million loan from Mizuho Bank. Additionally, it has ...

FYRA, a developer of low-latency mobile communication solutions leveraging 5G data and generative AI, announced on the 23rd that it has completed a seed funding round from D-Engine and individual ...

昨年末に開催された 01Booster Conference 2024 でカーブアウトセッションのモデレーターしてきました。ご参加いただいたみなさまありがとうございました。 新年あけましておめでとうございます。

GEIX folks visited Accenture Innovation Hub Tokyo. Image credit: Masaru Ikeda Do you remember Dave McClure, who once managed Founders Fund and 500 Startups (now 500 Global), and currently runs ...

Turing, a developer of autonomous driving systems, announced on the 25th that it has raised 1.02 billion yen in a pre-Series A extension round through investments from JIC Venture Growth Investments, ...

Starley, the developer of voice conversation AI app “Cotomo,” announced on the 25th that it has raised approximately 200 million yen through a third-party allocation of shares to investors including X ...

生成AI、XR、Web3から医療、農業まで——。新たな技術やビジネスモデルで既存市場に挑戦する革新的スタートアップが続々と登場しています。 2024年後半、Monthly Pitchに登壇した20社の取り組み ...

RadioNano Therapeutics, a biotech startup developing novel boron-containing nanoformulations for cancer treatment, announced on December 23 that it has secured approximately 150 million yen in the ...

MabGenesis, a biotechnology company specializing in antibody drug development, announced on the 24th that it has raised 470 million yen (approximately $3.2 million) in its latest funding round.